share_log

Cybin | 6-K: Report of foreign private issuer (related to financial reporting)

Cybin | 6-K: Report of foreign private issuer (related to financial reporting)

Cybin | 6-K：外国发行人报告（业绩相关）
美股SEC公告 ·  2024/08/15 15:52

Moomoo AI 已提取核心信息

Cybin will hold its Annual and Special Meeting on August 27, 2024, where shareholders will vote on several key proposals including a share consolidation of up to 50:1 ratio. The meeting will be held virtually via live webcast at https://web.lumiagm.com/249961995.The company seeks approval for amendments to its Equity Incentive Plan, including authority to amend option exercise prices and extend terms for non-Related Persons, and increasing available Incentive Stock Options to 151.9M shares. Additionally, shareholders will vote on amendments to the Shareholder Rights Plan and extending the maturity dates of 15.4M outstanding warrants by five years.Financial highlights show the company maintains a strong cash position of $208.9M as of March 31, 2024. The board will also present seven director nominees for election, including four independent directors, and shareholders will vote on the appointment of Zeifmans LLP as auditor.
Cybin will hold its Annual and Special Meeting on August 27, 2024, where shareholders will vote on several key proposals including a share consolidation of up to 50:1 ratio. The meeting will be held virtually via live webcast at https://web.lumiagm.com/249961995.The company seeks approval for amendments to its Equity Incentive Plan, including authority to amend option exercise prices and extend terms for non-Related Persons, and increasing available Incentive Stock Options to 151.9M shares. Additionally, shareholders will vote on amendments to the Shareholder Rights Plan and extending the maturity dates of 15.4M outstanding warrants by five years.Financial highlights show the company maintains a strong cash position of $208.9M as of March 31, 2024. The board will also present seven director nominees for election, including four independent directors, and shareholders will vote on the appointment of Zeifmans LLP as auditor.
Cybin将于2024年8月27日举行年度及特别会议，届时股东将对包括高达50:1比例的股票合并在内的若干关键提案进行投票。会议将通过实时网络直播形式举行，网址为https://web.lumiagm.com/249961995。公司寻求对其股权激励计划的修订批准，包括修订期权行使价格和为非关联人延长条款的权限，以及将可用的激励股票期权增至15190万股。此外，股东将对股东权利计划的修订进行投票，并将1540万未到期Warrants的到期日延长五年。财务亮点显示，截至2024年3月31日，公司保持强劲的现金储备，达20890万美元。董事会还将提名七位董事候选人进行选举，其中包括四位独立董事，股东将对Zeifmans LLP的审计师任命进行投票。
Cybin将于2024年8月27日举行年度及特别会议，届时股东将对包括高达50:1比例的股票合并在内的若干关键提案进行投票。会议将通过实时网络直播形式举行，网址为https://web.lumiagm.com/249961995。公司寻求对其股权激励计划的修订批准，包括修订期权行使价格和为非关联人延长条款的权限，以及将可用的激励股票期权增至15190万股。此外，股东将对股东权利计划的修订进行投票，并将1540万未到期Warrants的到期日延长五年。财务亮点显示，截至2024年3月31日，公司保持强劲的现金储备，达20890万美元。董事会还将提名七位董事候选人进行选举，其中包括四位独立董事，股东将对Zeifmans LLP的审计师任命进行投票。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    Eterna Therapeutics
    ERNA
    -- 0.518
    Matinas BioPharma
    MTNB
    -- 0.7201
    Oric Pharmaceuticals
    ORIC
    -- 9.825
    Biorestorative Therapies
    BRTX
    -- 1.770
    ZyVersa Therapeutics
    ZVSA
    -- 1.5000

    解锁榜首股票

    热门讨论
    特朗普2.0时代倒计时！全球股市的下一个风口？
    🎙️️讨论： 1. 加密货币政策能否利好crypto？ 2. 关税政策能否利好中概等海外资产？ 展开
    询问策略师 - 川普的首日
    查看更多